174 related articles for article (PubMed ID: 10082075)
1. Safety profile of Lansoprazole: the US clinical trial experience.
Freston JW; Rose PA; Heller CA; Haber M; Jennings D
Drug Saf; 1999 Feb; 20(2):195-205. PubMed ID: 10082075
[TBL] [Abstract][Full Text] [Related]
2. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Barradell LB; Faulds D; McTavish D
Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
[TBL] [Abstract][Full Text] [Related]
5. Rapid healing of gastric ulcers with lansoprazole.
Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
8. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Robinson M; Sahba B; Avner D; Jhala N; Greski-Rose PA; Jennings DE
Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
Langtry HD; Wilde MI
Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
12. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
Tolia V; Fitzgerald J; Hassall E; Huang B; Pilmer B; Kane R
J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S300-7. PubMed ID: 12607790
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
14. Proton-pump inhibition for acid-related disease.
Holt S
South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Berstad A; Hatlebakk JG
Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
17. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
18. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
[TBL] [Abstract][Full Text] [Related]
19. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
20. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]